[Recombinant human parathyroid hormone--new perspectives for anabolic therapy of osteoporosis].
Miazgowski
Tomasz
T
Klinika Endokrynologii, Nadciśnienia Tetniczego i Chorób Przemiany Materii PAM.
Stefański
Adam
A
D045930:Anabolic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control; D010281:Parathyroid Hormone / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use
D045930:Anabolic Agents; D010281:Parathyroid Hormone; D011994:Recombinant Proteins